Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEconomides, Nicholas-
dc.contributor.authorLopomo, Giuseppe-
dc.contributor.authorWoroch, Glenn-
dc.date.accessioned2006-01-30T16:10:27Z-
dc.date.available2006-01-30T16:10:27Z-
dc.date.issued1996-
dc.identifier.urihttp://hdl.handle.net/2451/14182-
dc.description.abstractThis paper evaluates the effectiveness of several pricing rules intended to promote entry into a network industry dominated by an incumbent carrier. Drawing on the work of Cournot and Hotelling, we develop a model of competition between two interconnected networks. In a symmetric equilibrium, the price of cross-network calls exceeds the price of internal calls. This 'calling circle discount' tends to 'tip' the industry to a monopoly equilibrium as would a network externality. By equalizing charges for terminating calls, reciprocity eliminates differences between internal and cross-network prices and makes monopoly less likely. Imputation counteracts an incentive by the dominant network to 'price squeeze' a rival by eliminating differences in the wholesale price of termination and the implicit price for internal use. By increasing profits of rival networks and increasing their subscribers' surplus, imputation supports additional entry. Finally, an unbundling rule reduces termination fees charged by a dominant network that was engaging in pure bundling. Again, entry will be facilitated as rival networks offer potential subscribers a more attractive rate schedule.en
dc.format.extent2843876 bytes-
dc.format.mimetypeapplication/pdf-
dc.languageEnglishEN
dc.language.isoen_US-
dc.publisherStern School of Business, New York Universityen
dc.relation.ispartofseriesIS-97-24-
dc.titleRegulatory Pricing Rules to Neutralize Network Dominanceen
dc.typeWorking Paperen
dc.description.seriesInformation Systems Working Papers SeriesEN
Appears in Collections:IOMS: Information Systems Working Papers

Files in This Item:
File Description SizeFormat 
97-24.pdf355.15 kBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.